Inhibition of Pro-Inflammatory Cytokines by Metabolites of Streptomycetes—A Potential Alternative to Current Anti-Inflammatory Drugs?
Current treatment of chronic diseases includes, among others, application of cytokines, monoclonal antibodies, cellular therapies, and immunostimulants. As all the underlying mechanisms of a particular diseases are not always fully clarified, treatment can be inefficient and associated with various,...
Main Authors: | Jiří Hrdý, Lenka Súkeníková, Petra Petrásková, Olga Novotná, David Kahoun, Miroslav Petříček, Alica Chroňáková, Kateřina Petříčková |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/8/5/621 |
Similar Items
-
Activation of a Cryptic Manumycin-Type Biosynthetic Gene Cluster of <i>Saccharothrix espanaensis</i> DSM44229 by Series of Genetic Manipulations
by: Dominika Gorniaková, et al.
Published: (2021-03-01) -
A Human Lung-Associated Streptomyces sp. TR1341 Produces Various Secondary Metabolites Responsible for Virulence, Cytotoxicity and Modulation of Immune Response
by: Andrej Herbrík, et al.
Published: (2020-01-01) -
Evolution of cyclizing 5-aminolevulinate synthases in the biosynthesis of actinomycete secondary metabolites: Outcomes for genetic screening techniques
by: Katerina ePetrickova, et al.
Published: (2015-08-01) -
Biocontrol of Cereal Crop Diseases Using Streptomycetes
by: Jake T. Newitt, et al.
Published: (2019-06-01) -
Anticancer Drug Discovery from Microbial Sources: The Unique Mangrove Streptomycetes
by: Jodi Woan-Fei Law, et al.
Published: (2020-11-01)